Fox Run Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,988
Closed -$668K 1244
2026
Q1
$668K Buy
+5,988
New +$837K 0.12% 318
2025
Q3
Sell
-5,339
Closed -$664K 1187
2025
Q2
$664K Sell
5,339
-13,509
-72% -$1.72M 0.11% 345
2025
Q1
$2.4M Buy
18,848
+14,213
+307% +$2.19M 0.37% 18
2024
Q4
$667K Buy
+4,635
New +$665K 0.12% 338
2024
Q3
Sell
-7,099
Closed -$895K 1054
2024
Q2
$895K Buy
7,099
+3,013
+74% +$472K 0.17% 214
2024
Q1
$751K Buy
+4,086
New +$778K 0.16% 235
2023
Q3
Sell
-6,862
Closed -$971K 944
2023
Q2
$971K Buy
6,862
+630
+10% +$101K 0.27% 88
2023
Q1
$1.05M Buy
+6,232
New +$1.11M 0.34% 53
2020
Q4
Sell
-1,719
Closed -$254K 269
2020
Q3
$254K Buy
+1,719
New +$246K 0.64% 72
2019
Q4
Sell
-3,361
Closed -$258K 509
2019
Q3
$258K Buy
+3,361
New +$294K 0.23% 214
2019
Q1
Sell
-8,652
Closed -$456K 652
2018
Q4
$456K Buy
+8,652
New +$507K 0.24% 135
2016
Q1
Sell
-8,400
Closed -$238K 530
2015
Q4
$238K Buy
+8,400
New +$242K 0.18% 254

Other funds holding RGEN

Fox Run Management's RGEN Position: Q2 2026 in Review

Fox Run Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 5,988 shares — an estimated $668K sold.

Fox Run Management first reported a position in RGEN in Q4 2015 and held it in 12 quarters. The position peaked at $2.4M in Q1 2025. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Fox Run Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 5,988 Repligen shares in Q2 2026, an estimated $668K.
  • Fox Run Management first reported a position in Repligen in Q4 2015 and held it in 12 quarters.
  • Fox Run Management's Repligen position peaked at $2.4M in Q1 2025.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.